miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition

References

• MolodeckyNA, SoonIS, RabiDM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42. doi:10.1053/j.gastro.2011.10.00122001864
   PubMed Web of Science ®Google Scholar
• OkayasuI, OhkusaT, KajiuraK, KannoJ, SakamotoS. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut. 1996;39(1):87–92. doi:10.1136/gut.39.1.878881816
   PubMed Web of Science ®Google Scholar
• EadenJA, AbramsKR, MayberryJF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–535. doi:10.1136/gut.48.4.52611247898
   PubMed Web of Science ®Google Scholar
• BernsteinCN, BlanchardJF, KliewerE, WajdaA. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91(4):854–862. doi:10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z11241255
   PubMed Web of Science ®Google Scholar
• LuJ, GetzG, MiskaEA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–838. doi:10.1038/nature0370215944708
   PubMed Web of Science ®Google Scholar
• IorioMV, CroceCM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27(34):5848–5856. doi:10.1200/JCO.2009.24.031719884536
   PubMed Web of Science ®Google Scholar
• ViennoisE, ZhaoY, HanMK, et al. Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans. Sci Rep. 2017;7(1):1–16. doi:10.1038/s41598-017-02782-128127051
   PubMed Web of Science ®Google Scholar
• WoalderA. Panel of methylated microRNA biomarkers for identifying high-risk patients with ulcerative colitis-associated colorectal cancer. Physiol Behav. 2017;153(6):1634–1646.e8. doi:doi:10.1053/j.gastro.2017.08.037
   Web of Science ®Google Scholar
• ChenXP, ChenYG, LanJY, ShenZJ. MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG. Cancer Lett. 2014;353(2):201–210. doi:10.1016/j.canlet.2014.07.02625063739
   PubMed Web of Science ®Google Scholar
• MengF, Wehbe-janekH, HensonR, SmithH, PatelT. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 2008;27(3):378–386. doi:10.1038/sj.onc.121064817621267
   PubMed Web of Science ®Google Scholar
• PengZ, WuT, LiY, et al. MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin. Brain Res. 2016;1644:53–61. doi:10.1016/j.brainres.2016.04.06627138069
   PubMed Web of Science ®Google Scholar
• ChenF, FengZ, ZhuJ, et al. Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway. Cancer Biol Ther. 2018;19(12):1139–1152. doi:10.1080/15384047.2018.148088830207869
   PubMed Web of Science ®Google Scholar
• HuangX, ZhuH, GaoZ, et al. Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by MIR-370-3p. J Biol Chem. 2018;293(18):6693–6706. doi:10.1074/jbc.RA118.00168929549123
   PubMed Web of Science ®Google Scholar
• WuZ, SunH, ZengW, HeJ, MaoX. Upregulation of mircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS One. 2012;7(9). doi:10.1371/journal.pone.0045825
   Web of Science ®Google Scholar
• LoSS, HungPS, ChenJH, et al. Overexpression of miR-370 and downregulation of its novel target TGFΒ-RII contribute to the progression of gastric carcinoma. Oncogene. 2012;31(2):226–237. doi:10.1038/onc.2011.22621666718
   PubMed Web of Science ®Google Scholar
• CaoX, LiuD, YanX, et al. Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor. FEBS Lett. 2013;587(6):639–644. doi:10.1016/j.febslet.2013.01.01223333300
   PubMed Web of Science ®Google Scholar
• MinM, PengL, YangY, GuoM, WangW, SunG. MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a. Inflamm Bowel Dis. 2014;20(4):652–659. doi:10.1097/MIB.000000000000000924583476
   PubMed Web of Science ®Google Scholar
• BandrésE, CubedoE, AgirreX, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5(1):1–10. doi:10.1186/1476-4598-5-2916403226
   PubMed Web of Science ®Google Scholar
• Rakoff-nahoumS, PaglinoJ, Eslami-varzanehF, EdbergS, MedzhitovR. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118(2):229–241. doi:10.1016/j.cell.2004.07.00215260992
   PubMed Web of Science ®Google Scholar
• KesharwaniSS, RajputM, TummalaH. Developing polymer-drug complex based toll-like receptor (TLR-2/TLR-4) antagonist for modulating gut innate immune system to prevent/treat IBD and colon cancer. J Immunol. 2017;198(1): 81-20.
   Web of Science ®Google Scholar
• KesharwaniSS, AhmadR, BakkariMA, et al. Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): formulation development, characterization and pharmacological evaluation. J Control Release. 2018;290:165–179. doi:10.1016/j.jconrel.2018.08.00430142410
   PubMed Web of Science ®Google Scholar
• LiH, WuWKK, LiZJ, et al. 2,3′,4,4′,5′-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice. Br J Pharmacol. 2010;160(6):1352–1361. doi:10.1111/j.1476-5381.2010.00785.x20590626
   PubMed Web of Science ®Google Scholar
• MuranoM, MaemuraK, HirataI, et al. Therapeutic effect of intracolonically administered nuclear factor κB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)- induced colitis. Clin Exp Immunol. 2000;120(1):51–58. doi:10.1046/j.1365-2249.2000.01183.x10759763
   PubMed Web of Science ®Google Scholar
• LashnerBA, BauerWM, RybickiLA, GoldblumJR. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis. Am J Gastroenterol. 2003;98(6):1423–1427. doi:10.1016/S0002-9270(03)00422-212818291
   PubMed Web of Science ®Google Scholar
• ShenX, ZuoX, ZhangW, BaiY, QinX, HouN. MiR‑370 promotes apoptosis in colon cancer by directly targeting MDM4. Oncol Lett. 2018;15(2):1673–1679. doi:10.3892/ol.2017.752429434862
   PubMed Web of Science ®Google Scholar
• TianD, ShaY, LuJM, DuXJ. MiR-370 inhibits vascular inflammation and oxidative stress triggered by oxidized low-density lipoprotein through targeting TLR4. J Cell Biochem. 2018;119(7):6231–6237. doi:10.1002/jcb.2685129663491
   PubMed Web of Science ®Google Scholar
• El-dalySM, AbbaML, PatilN, AllgayerH. MiRs-134 and-370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling. Sci Rep. 2016;6(November2015):1–11. doi:10.1038/srep2472028442746
   PubMed Web of Science ®Google Scholar
• YashiroM. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20(44):16389–16397. doi:10.3748/wjg.v20.i44.1638925469007
   PubMed Web of Science ®Google Scholar
• YaoD, DongM, DaiC, WuS. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm Bowel Dis. 2019;25(10):1595–1602. doi:10.1093/ibd/izz14931287863
   PubMed Web of Science ®Google Scholar
• ZhangY, ZhuY, GaoG, ZhouZ. Knockdown XIST alleviates LPS-induced WI-38 cell apoptosis and inflammation injury via targeting miR-370-3p/TLR4 in acute pneumonia. Cell Biochem Funct. 2019;37(5):348–358. doi:10.1002/cbf.339231066476
   PubMed Web of Science ®Google Scholar
• ZhangJ, MaoF, ZhaoG, WangH, YanX, ZhangQ. Long non-coding RNA SNHG16 promotes lipopolysaccharides-induced acute pneumonia in A549 cells via targeting miR-370-3p/IGF2 axis. Int Immunopharmacol. 2020;78(1):106065. doi:10.1016/j.intimp.2019.10606531841752
   PubMed Web of Science ®Google Scholar
• LongTM, RaufmanJP. The diagnostic and prognostic role of cytokines in colon cancer. Gastrointest Cancer Targets Ther. 2011;27. doi:10.2147/gictt.s18423
   Google Scholar
• ChanAT, OginoS, GiovannucciEL, FuchsCS. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterology. 2011;140(3):799–808.e2. doi:10.1053/j.gastro.2010.11.04121115010
   PubMed Web of Science ®Google Scholar
• BobeG, MurphyG, AlbertPS, et al. Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the polyp prevention trial. Br J Cancer. 2010;103(9):1453–1461. doi:10.1038/sj.bjc.660591520924374
   PubMed Web of Science ®Google Scholar
• KnüpferH, PreissR. Serum interleukin-6 levels in colorectal cancer patients-a summary of published results. Int J Colorectal Dis. 2010;25(2):135–140. doi:10.1007/s00384-009-0818-819898853
   PubMed Web of Science ®Google Scholar
• FukataM, ShangL, SantaolallaR, et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis. 2011;17(7):1464–1473. doi:10.1002/ibd.2152721674704
   PubMed Web of Science ®Google Scholar
• PaiR, SoreghanB, SzaboIL, PavelkaM, BaatarD, TarnawskiAS. Prostaglandin E2, transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002;8(3):289–293. doi:10.1038/nm0302-28911875501
   PubMed Web of Science ®Google Scholar
• BuchananFG, WangD, BargiacchiF, DuBoisRN. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem. 2003;278(37):35451–35457. doi:10.1074/jbc.M30247420012824187
   PubMed Web of Science ®Google Scholar
• SternLE, ErwinCR, O’brienDP, HuangF, WarnerBW. Epidermal growth factor is critical for intestinal adaptation following small bowel resection. Microsc Res Tech. 2000;51(2):138–148. doi:10.1002/1097-0029(20001015)51:2<138::AID-JEMT5>3.0.CO;2-T11054864
   PubMed Web of Science ®Google Scholar
• DannenbergAJ, LippmanSM, MannJR, SubbaramaiahK, DuBoisRN. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol. 2005;23(2):254–266. doi:10.1200/JCO.2005.09.11215637389
   PubMed Web of Science ®Google Scholar
• CoffeyRJ, HawkeyCJ, DamstrupL, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A. 1997;94(2):657–662. doi:10.1073/pnas.94.2.6579012840
   PubMed Web of Science ®Google Scholar
• LuX, YuY, TanS. p53 expression in patients with ulcerative colitis - associated with dysplasia and carcinoma: a systematic meta-analysis. BMC Gastroenterol. 2017;17(1):1–8. doi:10.1186/s12876-017-0665-y28049442
   PubMed Web of Science ®Google Scholar
• YazlovitskayaEM, DeHaanRD, PersonsDL. Prolonged wild-type p53 protein accumulation and cisplatin resistance. Biochem Biophys Res Commun. 2001;283(4):732–737. doi:10.1006/bbrc.2001.484911350044
   PubMed Web of Science ®Google Scholar
• SpadernaS, SchmalhoferO, HlubekF, et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology. 2006;131(3):830–840. doi:10.1053/j.gastro.2006.06.01616952552
   PubMed Web of Science ®Google Scholar
• ThieryJP, AcloqueH, HuangRYJ, NietoMA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890. doi:10.1016/j.cell.2009.11.00719945376
   PubMed Web of Science ®Google Scholar
• WangH, WangHS, ZhouBH, et al. Epithelial-Mesenchymal Transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer. PLoS One. 2013;8(2). doi:10.1371/journal.pone.0056664
   Web of Science ®Google Scholar
• WeiY, ShaoJ, WangY, et al. Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells. Mol Cell Biochem. 2019;450(1–2):159–166. doi:10.1007/s11010-018-3382-029922946
   PubMed Web of Science ®Google Scholar
• StanczakA, StecR, BodnarL, et al. Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma. Pathol Oncol Res. 2011;17(4):955–963. doi:10.1007/s12253-011-9409-421678109
   PubMed Web of Science ®Google Scholar
• JingYY, HanZP, SunK, et al. Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med. 2012;10(1):98. doi:10.1186/1741-7015-10-9822938142
   PubMed Web of Science ®Google Scholar
• TangS, JiangX, WuL, et al. Toll-like receptor 4 shRNA attenuates lipopolysaccharide-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells in rats. Biomed Pharmacother. 2018;107(June):1210–1217. doi:10.1016/j.biopha.2018.08.07130257335
   PubMed Web of Science ®Google Scholar
• LandskronG, De La FuenteM, ThuwajitP, ThuwajitC, HermosoMA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:1–19. doi:10.1155/2014/149185
   Web of Science ®Google Scholar
• Suarez-carmonaM, LesageJ, CataldoD, GillesC. EMT and inflammation: inseparable actors of cancer progression. Mol Oncol. 2017;11(7):805–823. doi:10.1002/1878-0261.1209528599100
   PubMed Web of Science ®Google Scholar